Retiro De Equipo (Recall) de VITROS Immunodiagnostic Products Estradiol Reagent Pack (used for the determination of estradiol in human serum). An in vitro diagnostic medical device (IVD)

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Ortho-Clinical Diagnostics.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
  • ID del evento
  • Clase de Riesgo del Evento
    Class II
  • Fecha de inicio del evento
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    Ortho clinical diagnostics (ortho) was made aware of the potential for medications that are derivatives of estrogen (e.G. fulvestrant) to interfere with estradiol immunoassays and cause positively biased sample results. ortho’s investigation confirmed positively biased estradiol results on samples obtained from postmenopausal females containing 30 ng/ml of fulvestrant (peak serum concentration of this therapeutic drug). fulvestrant is an estrogen receptor antagonist medication that blocks estrogen from tumors. due to the risk of the recently identified cross reactivity, estradiol assays should not be used to test patients being treated with fulvestrant.
  • Acción
    Ortho is advising users to use an alternative method for testing estradiol levels in patients being treated with fulvestrant. Users should be aware of the possibility of positively biased results. Consider the need to notify clinicians regarding estradiol results for women who are administered Fulvestrant. Customers are advised to discuss any concerns regarding previously reported results with you laboratory Medical Director. Ortho will be issuing revised Instructions for Use (IFU) to include additional information in the 'Limitation of Procedure' section. This action has been closed-out on 02/05/2017.


  • Modelo / Serial
    VITROS Immunodiagnostic Products Estradiol Reagent Pack (used for the determination of estradiol in human serum). An in vitro diagnostic medical device (IVD)Product Code: 8552630Lot Numbers: 1470, 1480, 1490, 1500, 1510, 1528, 1538, 1548, 1558, 1568ARTG Number: 176641
  • Manufacturer